Naglaa Ali Zayed

Dr. Naglaa Ali Zayed is a leading hepatology researcher specializing in viral hepatitis, particularly hepatitis C virus (HCV) and its complications such as hepatocellular carcinoma and liver steatosis. Her work spans clinical, genetic, and diagnostic innovations, with a strong focus on real-world patient outcomes in Egyptian populations.

Her research interests include:

• Genetic polymorphisms influencing liver disease severity
• miRNA biomarkers for HCV-mediated hepatocellular carcinoma
• Antiviral therapy efficacy in post-liver transplant patients
• Impact of public health policies during pandemics
• Real-world applications of direct-acting antivirals (DAAs)

Dr. Zayed's publications reflect her expertise in translational hepatology, with recent work analyzing acoustic radiation force impulse elastography, miRNA profiling, and pharmacological interventions for HCV. Her studies bridge molecular biology and clinical practice.

Research funding has been provided by prestigious organizations including:

• Centers for Disease Control and Prevention (CDC)
• Science and Technology Facilities Council (STFC)
• Deanship of Scientific Research, King Saud University
• King Abdullah University of Science and Technology (KAUST)
• Science and Technology Development Fund